Viking Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
18.33
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
5
|
|
# Buys
|
5
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.23
|
-0.21
|
0.02
|
8.70%
|
|
2022-06-30
|
-0.21
|
-0.23
|
-0.02
|
-9.52%
|
|
2022-03-31
|
-0.19
|
-0.21
|
-0.02
|
-10.53%
|
|
2021-12-31
|
-0.19
|
-0.16
|
0.03
|
15.79%
|
|
2021-09-30
|
-0.21
|
-0.17
|
0.04
|
19.05%
|
|
2021-06-30
|
-0.20
|
-0.20
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.17
|
-0.19
|
-0.02
|
-11.76%
|
|
2020-12-31
|
-0.15
|
-0.15
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.65
|
|
2021-12-31
|
-0.72
|
|
2020-12-31
|
-0.54
|
|
2019-12-31
|
-0.36
|
|
2018-12-31
|
-0.39
|
|
2017-12-31
|
-0.80
|
|
2016-12-31
|
-1.00
|
|
2015-12-31
|
-3.56
|